Contraception
RSSArticles
-
Investigational Contraceptive Patch Clears FDA Panel Vote
Twirla, an investigational combined hormonal contraceptive patch, is under review by the FDA. In an October 2019 meeting, the patch received a 14 to 1 vote from the FDA’s Bone, Reproductive, and Urologic Drugs Advisory Committee.
-
FDA Approves Liletta IUD for Six Years of Effective Use
The FDA has approved the Liletta levonorgestrel intrauterine device (IUD) for six years of effective use. The 52 mg device, similar in size to the Mirena IUD, was approved for the U.S. in February 2015.
-
The Time for Contraceptive Revolution Is Now
While the 20th century yielded new contraceptives in the form of pills, rings, patches, intrauterine devices, and implants, it is time for new exploration into further birth control options.
-
The Affordable Care Act: Progress in Reducing the Rate of Unintended Pregnancy
Data from the latest release of the National Survey of Family Growth supports that the contraception coverage mandate of the Affordable Care Act has resulted in a decrease in the incidence of unintended pregnancy, particularly among women with government coverage.
-
More Women Look to Self-Managed Medication Abortion
Results of a recent study indicated that online abortion medication demand is highest in states with restrictive abortion policies. Findings showed that from Oct.15, 2017, to Aug. 15, 2018, 6,022 people living in the United States requested abortion medications from an online service. While requests came from across the nation, states with restrictive abortion policies saw higher volumes of requests.
-
Crisis Pregnancy Center Care Is Focus of Adolescent Health Societies’ Statement
The Society for Adolescent Health and Medicine and the North American Society for Pediatric and Adolescent Gynecology have issued a joint position paper detailing how crisis pregnancy centers pose serious health risks for adolescents. According to the position paper, such centers fail to consistently follow medical and ethical practice standards, which could lead to negative health outcomes.
-
Antibiotic-Resistant Gonorrhea Remains Urgent Health Threat
The CDC recently released an update of its 2013 report, Antibiotic Resistance Threats in the United States, the first report to examine the threats posed by antibiotic resistance on human health. Antibiotic-resistant gonorrhea was listed as one of the three most urgent threats of its kind in the United States in 2013, and it retains its status as one of the five most urgent threats in the 2019 report.
-
Grocery Chain Expands Access to Contraceptives With Pharmacist Provision
Access to contraception has been broadened in seven Western states as Kroger Health pharmacists now offer contraceptive patches and self-administered hormonal contraceptive products.
-
Help Women With Chronic Conditions Choose the Most Effective Form of Contraception
One in three women of reproductive age has been diagnosed with at least one chronic condition that could lead to adverse health and pregnancy outcomes — yet few are using the most effective forms of birth control to prevent unplanned pregnancies, according to research from the University of Utah.
-
Educate Patients on Link Between HPV and Anal, Penile, Oral Cancers
Results of a new analysis led by researchers at The University of Texas Health Science Center at Houston indicate that more than 70% of U.S. adults do not know that human papillomavirus causes anal, penile, and oral cancers.